Pharmacologic properties of YM218, a novel, potent, nonpeptide vasopressin V1A receptor-selective antagonist-Reference-Cited by-同舟云学术

Pharmacologic properties of YM218, a novel, potent, nonpeptide vasopressin V1A receptor-selective antagonist

Published:2005-01 Issue:2 Volume:42 Page:47-55
ISSN:1537-1891
Container-title:Vascular Pharmacology
language:en
Short-container-title:Vascular Pharmacology

Author:

Tsukada Junko,Tahara Atsuo,Tomura Yuichi,Kusayama Toshiyuki,Wada Koh-ichi,Ishii Noe,Taniguchi Nobuaki,Suzuki Takeshi,Yatsu Takeyuki,Uchida Wataru,Shibasaki Masayuki

Publisher

Elsevier BV

Subject

Pharmacology,Molecular Medicine,Physiology

Reference52 articles.

1. Molecular cloning of the receptor for human antidiuretic hormone;Birnbaumer;Nature,1992

2. Tissue specificity of endothelin binding sites;Bolger;J. Cardiovasc. Pharmacol.,1990

3. Vasopressin in rats with genetic and streptozotocin-induced diabetes;Brooks;Diabetes,1989

4. Structural requirements for activation of vasopressin-sensitive adenylate cyclase, hormone binding, and antidiuretic actions;Butlen;Mol. Pharmacol.,1978

5. Calcium-mediated interactions between the antidiuretic hormone and renal plasma membranes;Campbell;J. Biol. Chem,1972

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxytocin and vasopressin modulate the social response to threat: a preclinical study;The International Journal of Neuropsychopharmacology;2014-05-07

2. Exploring the Ligand Recognition Properties of the Human Vasopressin V1a Receptor Using QSAR and Molecular Modeling Studies;Chemical Biology & Drug Design;2013-12-26

3. Effects of High Glucose on AVP-Induced Hyperplasia, Hypertrophy, and Type IV Collagen Synthesis in Cultured Rat Mesangial Cells;Endocrine Research;2012-05-17

4. Downregulation of vasopressin V1A receptors and activation of mitogen-activated protein kinase in rat mesangial cells cultured under high-glucose conditions;Clinical and Experimental Pharmacology and Physiology;2012-04-23

5. In vitro and in vivo pharmacological characterisation of the potent and selective vasopressin V1A receptor antagonist 4-[4-(4-Chloro-phenyl)-5-[1,2,3]triazol-2-ylmethyl-4H-[1,2,4]triazol-3-yl]-piperidin-1-yl-(3,5-difluoro-phenyl) methanone (PF-00738245);European Journal of Pharmacology;2011-11